Skip to contentSkip to footer
Harvard Pilgrim Health Care
  • Members
  • Employers
  • Brokers
  • Providers
  • Contact Us
  • PROVIDER MENU
    • Prior Authorization
      • Commercial Clinical/Authorization Policies
      • Vendor Programs
    • Medicare Advantage
      • About Our StrideSM (HMO)/(HMO-POS) Medicare Advantage Plans
      • Medicare Advantage Forms
      • Compliance Program
      • Medicare Advantage Clinical/Auth. Policies
      • Provider Manual for Medicare Advantage
    • Billing and Reimbursement
    • Pharmacy
      • Formulary Lookup & Preventive Drug Lists
      • Clinical Coverage Criteria and Request Forms
      • Ways to Order Medication
      • Exception Requests
    • Provider Manual
      • Network Operations & Care Delivery Management
      • Member Care
      • Referral, Notification & Authorization
      • eServices & Online Solutions
      • Billing & Reimbursement
      • Appeals
      • Payment Policies
    • Caring for Your Patient
    • Resource Center
      • Join Our Network
      • Commercial Forms
      • Electronic Tools and HPHConnect
      • Provider Training and Events
    • Learn About Our Products
      • Tiered Network Product Resources
    • Network Medical Management & Quality
      • Quality Initiatives
      • Medical Directors Meetings
      • Physician Group Honor Roll
      • LCU Reporting
    • News Center
      • COVID-19 Information and Resources
      • Network Matters
    • COVID-19 Information and Resources
    • HPHC-THP Combination
  • Provider Directory
  • Provider Login
Back to Commercial Clinical/Authorization Policies

Medical Drug Prior Authorization (CVS Health-Novologix)

CVS Health–NovoLogix conducts medical necessity and utilization review for the following medical drugs on behalf of Harvard Pilgrim — when they are used for purposes other than oncology. If you are utilizing a medical drug for oncology, prior authorization is necessary through OncoHealth (formerly Oncology Analytics). For more information, please refer to these resources: the OncoHealth link on the Medical/Clinical Policies webpage and the vendor programs resource page.

The following CVS Health–NovoLogix criteria are valid for dates of service beginning Sept. 1, 2020 and include dose and frequency guideline information.

Search Filters

  • Q

Documents in this collection

Dosage Exceptions

Prior Authorization Exception Criteria

Additional Resources

Obtaining Medical Drugs through Specialty Pharmacy

Novologix portal user guide

Provider Tools & Resources

  • Electronic Tools & Transactions
  • Quality Initiatives
  • LCU Reporting
  • Medical Directors Meetings
  • Identify Your PRC and Other Key Contacts

About Us

  • Careers at Point32Health
  • Newsroom
  • Research & Teaching
  • Our Foundation
  • Contact Us
  • Privacy & Disclaimer Statements

Switch Sites

  • For Brokers
  • For Employers
  • For Members

Nondiscrimination

  • Español (Spanish)
  • Português (Portuguese)
  • Kreyòl Ayisyen (French Creole)
  • 繁體中文 (Traditional Chinese)
  • Tiếng Việt (Vietnamese)
  • Русский (Russian)
  • العربية (Arabic)
  • ខ្មែរ (Cambodian)
  • Français (French)
  • Italiano (Italian)
  • 한국어 (Korean)
  • Eλληνικά (Greek)
  • Polski (Polish)
  • हिंदी (Hindi)
  • ગુજરાતી (Gujarati)
  • English (English)
  • ພາສາລາວ (Lao)

ATTENTION: If you speak a language other than English, language assistance services, free of charge, are available to you. Call 1-888-333-4742 (TTY: 711).

© 2022 Harvard Pilgrim Health Care, Inc. All rights reserved.

Privacy and Disclaimer Statements

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube